Propanc Biopharma Inc

CUSIP 74346N701COM NEWPPCBQ4 2025

Propanc Biopharma Inc — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

9.9%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

2 filings · latest Nov 14, 2025

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Nov 14, 2025	Ionic Ventures, LLC	13G/A	—	—	SEC
2	Aug 19, 2025	Ionic Ventures, LLC	13G	9.9%	1.26M	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Marex Group PLC	65.0K	$35.1K
2	Two Sigma Securities, LLC	25.5K	$13.7K
3	Xtx Topco Ltd	22.1K	$11.9K
4	Two Sigma Investments, LP	16.3K	$8.7K
5	Morgan Stanley	1	$1